TrumpCare hasn’t hit healthcare stocks yet
Mergers are driving up biotech stocks, but beware of short traders.
Tech stocks aren’t likely to crash, but valuations are looking pricey.
Why US stocks are in an uptrend.
I’ve liquidated all my holdings in marijuana stocks for now.
The US stock bull market seems intact.
After a big 2013 sector rally, Robert Freedland looks ahead to next year.
I bought into the fast-growing industries via two exchange traded funds.
3D Systems is pricey but has a promising future.
Here’s my bullish case for 3D Systems.
Here’s why we took a position in the iShares NASDAQ Biotechnology Index.
Philip Pecoraro shares his technical analysis